Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.

Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA.

PLoS One. 2009 Oct 12;4(10):e7405. doi: 10.1371/journal.pone.0007405.

2.

Serum miR-574-5p: a prognostic predictor of sepsis patients.

Wang H, Meng K, Chen Wj, Feng D, Jia Y, Xie L.

Shock. 2012 Mar;37(3):263-7. doi: 10.1097/SHK.0b013e318241baf8.

PMID:
22344312
3.

Four serum microRNAs identified as diagnostic biomarkers of sepsis.

Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX.

J Trauma Acute Care Surg. 2012 Oct;73(4):850-4. doi: 10.1097/TA.0b013e31825a7560.

PMID:
23026916
4.

[Relationship between expression of microRNA and inflammatory cytokines plasma level in pediatric patients with sepsis].

Wu Y, Li C, He Y, Li Q, Wang G, Wen P, Yang W, Yang Y.

Zhonghua Er Ke Za Zhi. 2014 Jan;52(1):28-33. Chinese.

PMID:
24680405
5.

Elevated miR-155 expression induces immunosuppression via CD39(+) regulatory T-cells in sepsis patient.

Liu J, Shi K, Chen M, Xu L, Hong J, Hu B, Yang X, Sun R.

Int J Infect Dis. 2015 Nov;40:135-41. doi: 10.1016/j.ijid.2015.09.016. Epub 2015 Oct 1.

6.

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.

Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR, Zhang W.

PLoS One. 2011 Mar 17;6(3):e17745. doi: 10.1371/journal.pone.0017745.

7.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
8.

Serum miR-146a and miR-223 as potential new biomarkers for sepsis.

Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, Zhu KM.

Biochem Biophys Res Commun. 2010 Mar 26;394(1):184-8. doi: 10.1016/j.bbrc.2010.02.145. Epub 2010 Feb 24.

PMID:
20188071
9.

Serum levels of microRNAs in patients with heart failure.

Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O.

Eur J Heart Fail. 2012 Feb;14(2):147-54. doi: 10.1093/eurjhf/hfr155. Epub 2011 Nov 25.

10.

Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.

Yabushita S, Fukamachi K, Tanaka H, Sumida K, Deguchi Y, Sukata T, Kawamura S, Uwagawa S, Suzui M, Tsuda H.

Pancreas. 2012 Oct;41(7):1013-8. doi: 10.1097/MPA.0b013e31824ac3a5.

PMID:
22513294
11.

MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.

Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY.

J Surg Oncol. 2012 Feb;105(2):175-82. doi: 10.1002/jso.22066. Epub 2011 Aug 22.

PMID:
21882196
12.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
13.

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W.

J Surg Oncol. 2011 Dec;104(7):847-51. doi: 10.1002/jso.22008. Epub 2011 Jun 30.

PMID:
21721011
14.

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.

Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M.

PLoS One. 2009;4(5):e5532. doi: 10.1371/journal.pone.0005532. Epub 2009 May 14.

15.

Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.

Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, Lynch JM, Hullinger TG, Seto AG, van Rooij E.

Eur J Heart Fail. 2013 Jun;15(6):650-9. doi: 10.1093/eurjhf/hft018. Epub 2013 Feb 6.

16.

Assessment of plasma miRNAs in congestive heart failure.

Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N.

Circ J. 2011;75(2):336-40. Epub 2010 Dec 9.

17.

Circulating microRNAs in plasma of patients with gastric cancers.

Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2010 Mar 30;102(7):1174-9. doi: 10.1038/sj.bjc.6605608. Epub 2010 Mar 16.

18.

Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection.

Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Lau WB, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen AF, Yang X, Cai J.

Circulation. 2011 Jul 12;124(2):175-84. doi: 10.1161/CIRCULATIONAHA.110.012237. Epub 2011 Jun 20.

19.

Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients.

Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S, Zhang Z.

Dig Dis Sci. 2012 Apr;57(4):897-904. doi: 10.1007/s10620-011-1981-7. Epub 2011 Dec 25.

PMID:
22198701
20.

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M.

Am J Pathol. 2012 May;180(5):1808-15. doi: 10.1016/j.ajpath.2012.01.034. Epub 2012 Mar 15.

PMID:
22426337

Supplemental Content

Support Center